TMJ sufferers: could a simple injection stop the clicking?

NCT ID NCT06403046

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed trial tested two anti-inflammatory drugs, tenoxicam and meloxicam, injected into the jaw joint after a routine washout procedure. The goal was to reduce pain, clicking, and improve mouth opening in 30 adults with a specific type of TMJ disorder. The study compares which drug works better for symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Tenoxicam and Meloxicam (anti-inflammatory drugs)

What this could lead to

If successful, this could point toward a simple injection-based treatment to ease TMJ pain and clicking without surgery.

What could go wrong

This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. The treatment targets symptoms, not the underlying disc position.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TEMPOROMANDIBULAR JOINT DISC DISPLACEMENT, WITH REDUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beni-suef university

    Banī Suwayf, Egypt